• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Nordic American Tankers Posts Upbeat Results

    5/22/23 9:50:08 AM ET
    $AVIR
    $GRND
    $HEPA
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $AVIR alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones trading slightly lower on Monday.

    Following the market opening Monday, the Dow traded down 0.01% to 33,422.94 while the NASDAQ rose 0.09% to 12,669.27. The S&P 500, also rose, gaining, 0.08% to 4,195.41.

    Check This Out: Top 5 Consumer Stocks That May Explode In May

     

    Leading and Lagging Sectors

    • Communication services shares rose by 1.5% on Monday. Meanwhile, top gainers in the sector included Grindr Inc. (NYSE:GRND), up 5%, and Vimeo, Inc. (NASDAQ:VMEO), up 5%.
    • In trading on Monday, consumer staples shares fell 0.4%.

     

    Top Headline

    Nordic American Tankers Limited (NYSE:NAT) reported better-than-expected first-quarter results.

    Nordic American Tankers reported a first-quarter FY23 revenue increase of 461.1% year-over-year to $87.09 million, beating the consensus of $80.03 million. EPS for the quarter improved to $0.22 from a loss per share of $(0.14) in 1Q22, beating the consensus of $0.20.

     

    Equities Trading UP

    • Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) shares shot up 54% to $13.66 after the company announced results of its phase 2 study to treat liver function.
    • Shares of VectivBio Holding AG (NASDAQ:VECT) got a boost, shooting 39% to $16.28 after Ironwood Pharmaceuticals announced it would acquire the company for $17 per share.
    • Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) shares were also up, gaining 30% to $4.8115. Tang Capital Partners, Concentra sent acquisition proposal to Atea Pharmaceuticals with terms to acquire all of its outstanding common stock.

     

    Equities Trading DOWN

    • Rain Oncology Inc. (NASDAQ:RAIN) shares dropped 84% to $1.6300 after the company’s Phase 3 MANTRA trial of milademetan in dedifferentiated liposarcoma, did not meet its primary endpoint of progression-free survival, compared to the standard of care, trabectedin.
    • Shares of Mallinckrodt plc (NYSE:MNK) were down 35% to $4.09.
    • Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) was down, falling 18% to $11.19. FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceuticals’ Ocaliva 25 mg, also known as Obeticholic acid (OCA), don't outweigh the risks in nonalcoholic steatohepatitis (NASH) patients with stage 2 or 3 fibrosis.

    Also Check This Out: $4.7M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying

     

    Commodities

    In commodity news, oil traded down 0.3% to $71.37 while gold traded down 0.2% at $1,976.80.

    Silver traded down 0.7% to $23.895 on Monday while copper fell 1.1% to $3.6905.

     

    Euro zone

    European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.2%, London’s FTSE 100 fell 0.1% while Spain’s IBEX 35 Index rose 0.5% The German DAX declined 0.4%, French CAC 40 fell 0.4% and Italy’s FTSE MIB Index fell 1%.

    Construction output in the Eurozone dropped by 1.5% year-over-year in March versus a revised growth of 2.1% in the prior month.

     

    Asia Pacific Markets

    Asian markets closed higher on Monday, with Japan’s Nikkei 225 gaining 0.90%, Hong Kong’s Hang Seng Index gaining 1.17% and China’s Shanghai Composite Index gaining 0.39%. India’s S&P BSE Sensex rose 0.3%.

    The annual inflation rate in Hong Kong increased to 2.1% in April from 1.7% in the prior two months. The People's Bank of China kept its key lending rates unchanged at the May fixing. Japan's core machinery orders slipped 3.9% month-over-month in March.

     

    Economics

    There were no major US economic releases Monday.

    Now Read This: Check Out 3 Energy Stocks With Over 6% Dividend Yields From Wall Street's Most Accurate Analysts

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,042,460 cases with around 1,164,340 deaths. India confirmed a total of at least 44,986,930 cases and 531,830 deaths, while France reported over 40,054,860 COVID-19 cases with 167,050 deaths. In total, there were at least 689,013,300 cases of COVID-19 worldwide with more than 6,880,500 deaths.

    Get the next $AVIR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVIR
    $GRND
    $HEPA
    $ICPT

    CompanyDatePrice TargetRatingAnalyst
    Grindr Inc.
    $GRND
    2/24/2026$14.00Equal-Weight
    Morgan Stanley
    Grindr Inc.
    $GRND
    6/30/2025$27.00Mkt Outperform
    Citizens JMP
    Grindr Inc.
    $GRND
    12/16/2024$20.00Buy
    Goldman
    Vimeo Inc.
    $VMEO
    12/10/2024$7.00 → $10.00Neutral → Overweight
    Piper Sandler
    Nordic American Tankers Limited
    $NAT
    9/12/2024$4.00Buy → Hold
    Jefferies
    Atea Pharmaceuticals Inc.
    $AVIR
    8/13/2024$2.00 → $6.88Underweight → Equal-Weight
    Morgan Stanley
    Grindr Inc.
    $GRND
    6/27/2024$14.00 → $15.00Outperform
    Raymond James
    Grindr Inc.
    $GRND
    6/27/2024$14.00 → $17.00Mkt Outperform
    JMP Securities
    More analyst ratings

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Grindr with a new price target

    Morgan Stanley initiated coverage of Grindr with a rating of Equal-Weight and set a new price target of $14.00

    2/24/26 7:55:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Citizens JMP initiated coverage on Grindr with a new price target

    Citizens JMP initiated coverage of Grindr with a rating of Mkt Outperform and set a new price target of $27.00

    6/30/25 8:51:37 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Goldman initiated coverage on Grindr with a new price target

    Goldman initiated coverage of Grindr with a rating of Buy and set a new price target of $20.00

    12/16/24 6:28:30 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zage George Raymond Iii bought $675,500 worth of shares (50,000 units at $13.51), increasing direct ownership by 0.62% to 8,113,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/9/25 6:47:20 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Zage George Raymond Iii bought $2,091,000 worth of shares (155,000 units at $13.49), increasing direct ownership by 1% to 8,063,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/5/25 5:00:05 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Zage George Raymond Iii bought $2,651,000 worth of shares (200,000 units at $13.26), increasing direct ownership by 1% to 7,983,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/4/25 5:15:57 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AVIR
    $GRND
    $HEPA
    $ICPT
    SEC Filings

    View All

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AVIR
    $GRND
    $HEPA
    $ICPT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    Large owner Lu James Fu Bin sold $14,595,500 worth of shares (1,450,000 units at $10.07) (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    2/6/26 7:50:44 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Richardson Nathan sold $16,770 worth of shares (1,500 units at $11.18), decreasing direct ownership by 10% to 12,833 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    2/4/26 4:16:15 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Large owner Lu James Fu Bin sold $6,756,134 worth of shares (612,766 units at $11.03) (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    2/3/26 9:06:10 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Grindr Inc. filed SEC Form 8-K: Shareholder Director Nominations, Financial Statements and Exhibits

    8-K - Grindr Inc. (0001820144) (Filer)

    2/24/26 4:08:31 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    SEC Form 424B3 filed by Rain Enhancement Technologies Holdco Inc.

    424B3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)

    2/20/26 4:47:32 PM ET
    $RAIN
    Industrial Machinery/Components
    Technology

    Rain Enhancement Technologies Holdco Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)

    2/20/26 4:46:56 PM ET
    $RAIN
    Industrial Machinery/Components
    Technology

    Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026

    Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus  Initiation of Phase 1 Clinical Program Anticipated Mid-2026 BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced in vitro results showing that two proprietary oral nucleotide analogs, AT-587 and AT-2490, exhibit promising antiviral profiles as potential first-in-class inhibitors for the treatment of Hepatitis E virus (HEV) infection, a positive-sense, single-stranded RNA virus that primarily infec

    2/24/26 7:00:00 AM ET
    $AVIR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Grindr Announces Date of Fourth Quarter and Full Year 2025 Financial Results Earnings Call

    Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, after the market closes on Thursday, February 26, 2026. Grindr will issue a press release when its Shareholder Letter has been posted to its Investor Relations website at https://investors.grindr.com. Following the release of the Shareholder Letter, Grindr will host a webcasted conference call to discuss its results. Earnings Webcast Information Event: Grindr Fourth Quarter and Full Year 2025 Earnings Conference Call Date: Thursday, February 26, 2026 Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Live

    2/12/26 4:05:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Nordic American Tankers Ltd (NYSE: NAT) – A 2003-built vessel sold for $25 million

      Monday, February 9, 2026 Dear Shareholders and Investors,I am pleased to announce that we have entered into a sales agreement for a 2003-built suezmax tanker. The sales price of the ship is $25 million net to us and the ship has no debt. Nordic American Tankers Ltd. is in a solid position.  Sincerely, Herbjorn HanssonFounder, Chairman & CEO Nordic American Tankers Ltd.                                                        www.nat.bm Contacts:        Bjørn Giæver, CFO                                                             Nordic American Tankers Ltd                                             Tel: +1 888 755 8391                                   Alexander Kihle, Finance Man

    2/9/26 9:27:50 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-8) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 02/24/2022. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    2/25/22 4:36:46 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-7) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 05/26/2021. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    5/27/21 5:23:24 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Leadership Updates

    Live Leadership Updates

    View All

    Grindr Announces Leadership Appointments

    Tristan Pineiro Appointed Chief Marketing Officer; Zac Katz Named Chief Legal Officer Grindr Inc., the Global Gayborhood in Your Pocket™, today announced the appointment of Tristan Pineiro to Chief Marketing Officer and Zac Katz to Chief Legal Officer, General Counsel, and Head of Global Affairs, effective immediately. "These appointments reflect the scope and responsibility Zac and Tristan deliver on daily," said George Arison, CEO of Grindr. "They are distinctive leaders who consistently raise the bar on how we execute on our ambitious vision for Grindr." Pineiro has led a significant repositioning of Grindr's brand through the Global Gayborhood platform, strengthening cultural rele

    1/9/26 9:00:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    AUTOCANADA APPOINTS FADE BOURAS AS CHIEF OPERATING OFFICER AND JOHN NORTH TO ITS BOARD OF DIRECTORS

    EDMONTON, AB, Dec. 15, 2025 /CNW/ - AutoCanada Inc. ("AutoCanada" or the "Company") (TSX:ACQ), a leader in Canadian automotive retail, today announced the appointment of Fade Bouras as Chief Operating Officer, effective January 15, 2026. The Company also announced the appointment of John North to its Board of Directors, effective immediately. Appointment of Fade Bouras as Chief Operating Officer Mr. Bouras brings more than 22 years of automotive retail experience, having built his career across every major function within dealership operations. Most recently, he served as Chief Operating Officer of HGrégoire, where he led a large, high-volume, multi-location automotive retail platform and o

    12/15/25 6:25:00 PM ET
    $GRND
    $LAD
    $XPEL
    Computer Software: Programming Data Processing
    Technology
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    ReAlta Life Sciences Appoints Dr. Howard Berman as Executive Chairman

    ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to revolutionize the treatment of inflammatory disorders, today announced the appointment of Howard Berman, Ph.D., as Executive Chairman of the ReAlta Life Sciences Board of Directors, effective immediately. "We are delighted to welcome Howard to ReAlta at a pivotal moment for the Company as we move towards meaningful catalysts," said Kenji Cunnion, M.D., MPH, Co-Founder, Chief Medical Officer and Board Member of ReAlta. "His proven track record in advancing innovative immunology-based therapies and creatin

    11/25/25 8:00:00 AM ET
    $AVIR
    $COYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Financials

    Live finance-specific insights

    View All

    Grindr Announces Date of Fourth Quarter and Full Year 2025 Financial Results Earnings Call

    Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, after the market closes on Thursday, February 26, 2026. Grindr will issue a press release when its Shareholder Letter has been posted to its Investor Relations website at https://investors.grindr.com. Following the release of the Shareholder Letter, Grindr will host a webcasted conference call to discuss its results. Earnings Webcast Information Event: Grindr Fourth Quarter and Full Year 2025 Earnings Conference Call Date: Thursday, February 26, 2026 Time: 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Live

    2/12/26 4:05:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Nordic American Tankers Ltd (NYSE: NAT) – Mandatory notification - The Hansson family purchase more shares and passes 5% ownership in NAT

      Monday, December 22, 2025   Dear Shareholders and Investors, I am pleased to disclose that I, as the Founder, Chairman & CEO of NAT, today have bought 200,000 shares at $3.50 per share, bringing my total holding to 5,300,000 shares. Simultaniously, my son, Alexander Hansson, Vice-Chair of NAT has bought 200,000 shares at $3.50 per share, bringing his holding to 5,350,000 shares. Following this transaction, our family collectively owns 10,650,000 shares and has passed the 5% threshold, requiring this mandatory notification to the market. As in the past, the Hansson family is the largest private shareholder group in the company. NAT has paid dividend for 113 consequitive quarters, af

    12/22/25 9:37:30 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    Nordic American Tankers Ltd (NYSE: NAT) – Report as per September 30, 2025 – Increased dividend and solid prospects

    Friday, November 28, 2025   Dear Shareholders and Investors, The direction of NAT is on the upswing. Safety for crew, safety for ships and dividends remain our main priorities. The so-called grey/black fleet is invalidated, reducing the available fleet in the market place and improving the position of NAT. Our ships have not carried Russian oil for more than four years. Major oil companies are the main customers of NAT.  Ninety day periods offer a short-term snapshot of NAT. A more meaningful analysis must contain a longer-term picture.    Highlights:              The dividend for the third quarter is 13 cents ($0.13) per share. This is our 113th consecutive quarterly cash divid

    11/28/25 5:13:24 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    $AVIR
    $GRND
    $HEPA
    $ICPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Grindr Inc.

    SC 13D/A - Grindr Inc. (0001820144) (Subject)

    12/9/24 5:32:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Atea Pharmaceuticals Inc.

    SC 13G/A - Atea Pharmaceuticals, Inc. (0001593899) (Subject)

    11/15/24 10:34:54 AM ET
    $AVIR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Hepion Pharmaceuticals Inc.

    SC 13G/A - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

    11/14/24 4:07:59 PM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care